Friday, December 14, 2012

How Does Hip Pain Occur and Is There a Real Solution?


In order to truly restore proper alignment to the hip area, it is fundamental to correct the misalignment of forces coming from the legs. This, in turn, takes us to the root of the problem, which is located in the ankle and heel area of the foot. The leg’s balance – and in fact that of the entire body – rests on this area. Proper stability of the ankle bone over the hindfoot bones is fundamental in maintaining a healthy leg and hip alignment. When the stability of the ankle bone over the hindfoot bones is lost, this area collapses, turning inwards, creating a condition called partial talotarsal dislocation.

Patients suffering from hip pain as a consequence of imbalances can find the true source of their hip problems in their feet. Talotarsal displacement causes the foundation of the leg, the rearfoot, to shift inwards, creating a complex misalignment of forces that gets transferred up the leg and into the hip area, causing damage to joints and other tissues.

HyProCure® can resolve partial talotarsal dislocation instantly and permanently through a brief, minimally invasive procedure, restoring foot stability and proper balance. As a direct benefit, this will also restore proper leg and hip alignment, eliminating excessive unnatural forces from the unstable foot structure that caused the abnormal tissue strain and wear-and-tear in the joints.

Locate a HyProCure® specialist near you at www.hyprocure.com/doctor-locator.

Monday, December 10, 2012

HyProCure® is Scientifically Proven to Eliminate Excessive Joint Forces within the Foot

Instability of the hindfoot bones leads to excessive abnormal forces acting on the ligaments and tendons on the inner-side of the foot. Once HyProCure® is placed into the foot and stabilized the ankle bone, these forces are restored back to normal.

The effects of partial talotarsal dislocation include fallen arches, bunions, overpronation, Achilles tendonitis, posterior tibial tendon dysfunction, and pain in the foot, ankle, knee, hip, back or even shoulder and jaw area. The HyProCure® device instantly stabilizes the ankle bone on the hindfoot bones, leading to reversal of the associated effects of the dislocation.

Learn more at www.HyProCure.com.

Find summaries to published research here.

Wednesday, December 5, 2012

Treatment for Bunions

The Problem: Moderate to Severe Bunions

Bunions are a common problem that most people experience as a bony protuberance at the base of the big toe. When a patient has a bunion, the big toe angles in toward the other toes, a condition called hallux valgus.

As the big toe becomes more and more angled (pointing toward the other toes), the base of the toe becomes more and more prominent, forming the bunion. The bunion forms in part because of the new angle of the toe, and in part due to inflammation over the bunion surface. As the inflammation worsens, people can experience pain with shoe wear and walking.

The big toe may eventually come to lie over, or more commonly under, the second toe. This may cause further irritation while wearing shoes and more pain. The second toe of patients who have bunions commonly forms a hammer toe.

The Solution: Introducing osteo-WEDGETM


Traditional bunion corrective surgical techniques are like cutting a wedge out of the leaning tower of Pisa to make it straight when the real problem was with the foundation. The osteo-WEDGETM Open Wedge Bone Locking System fixes the deformity at its foundation. With osteo-WEDGETM, patients and foot surgeons have a new option for permanent correction, without the limitations of other methods. The procedure is less invasive and patients should experience a quicker recovery than they would with the alternates.

Click here for FAQs.

Thursday, November 22, 2012

Wednesday, November 14, 2012

What are the indications for osteo-WEDGETM?

The osteo-WEDGETM Opening Wedge Bone Locking Plate System can be used in adult and transitional adolescent (18 to 21 years old) patients for the purpose of stabilization and/or correction of angular deviations within an individual bone or in between two adjacent bones in the foot, such as opening wedge osteotomy for the first metatarsal cuneiform joint deviations. There are no known contra-indications.

 

 Learn more at www.GraMedica.com

Monday, November 12, 2012

What are the advantages of the osteo-WEDGETM Bone Locking Plate and Screw System?

The osteo-WEDGETM system was designed to overcome the limitations of other devices and procedures. Advantages include:

  • Ability to lengthen, shorten or maintain metatarsal length
  • Ability to plantarflex or dorsiflex the metatarsal – sagittal plane correction
  • Ability to correct an increased first metatarsal angle – transverse plane correction
  • Dorsomedial application at the 1st metatarsal medial cuneiform joint to counteract weight bearing forces
  • Six points (three proximally and three distally) of locking screw fixation for maximum stability
  • Thin (1mm), low profile, but strong titanium configuration
  • Allows for easy and accurate placement
  • May allow for early weightbearing

Monday, October 29, 2012

Possible Secondary Pathologies of Partial TaloTarsal Dislocation

The following conditions/pathologies may be caused by or have symptoms increased by talotarsal displacement:

PTTD (posterior tibial tendon dysfunction)
Plantar fasciitis
Achilles tendonitis
First ray deformities/bunions
Navicular drop (fallen arches)
Tarsal tunnel syndrome
Posterior tibial neuropathy
Musculoskeletal pain – knees, hips, back, etc

Find our more at www.GraMedica.com.

Saturday, October 27, 2012

Verifying Candidacy for Extra-Osseous TaloTarsal Stabilization with HyProCure®

It is important to document the presence of reducible/flexible talotarsal displacement. This is accomplished through:

Clinical exam
  • Weightbearing: To check for potential reducibility as the foot transitions from neutral to relaxed stance position.
  • Non-weightbearing range of motion exam: A stable talotarsal mechanism will have little triplane motion. Tested by loading the 4th and 5th metatarsal heads and moving the foot from a pronated to supinated position and back.
  • Gait analysis: Looking for evidence that could include “too many toes” sign, a prolonged period of pronation, calcaneal valgus and/or abductory twist.
Radiographic Analysis
  • Partial talotarsal dislocation can be seen in Lateral and AP weightbearing views.
  • It is important to take both as the deformity can have planal dominance.
  • If the deformity is flexible, neutral stance position x-rays should show normal radiographic measurements.
    • AP View

  • Talar 2nd metatarsal angle

  • Bisection of the talus should align lateral to the medial aspect of the 1st metatarsal


      •  Lateral View
    • Talar declination angle
    • Talocalcaneal angle“Open” sinus tarsi
    • Sustentaculum tali slightly dorsiflexed
    • Normal cyma line
    • Normal navicular height
    • In relaxed stance, will see at least one of the following:
      • AP view:
    • Talar 2nd metatarsal angle >16 degrees
    • Bisection of the talus medial to the medial aspect of the 1st metatarsal
      • Lateral view
    • Talus anteriorly displaced on the cyma line
    • Sustentaculum tali slightly plantarflexed
    • Loss of navicular height/navicular drop
    • Talar declination angle >21 degrees
    • Talocalcaneal angle >46 degrees

    Thursday, October 18, 2012

    Importance of Foot Alignment

    The foot is the foundation to the body. The alignment of the foot is crucial for proper foot function. This lecture discusses normal and abnormal alignment and the exact cause that leads to a faulty foot structure. Learn more at www.GraMedica.com.

    Tuesday, October 16, 2012

    GraMedica®: Our Core Beliefs

    We live up to our name! In the service of our customers, both patients and surgeons, we stand for Growth, Responsibility, Ambition, Motivation, Education, Dedication, Integrity, Customer Satisfaction and Accountability.



    Learn more here.

    Monday, October 15, 2012

    Adult Acquired Flatfoot

    Adult acquired is a very serious condition that can lead to many secondary deformities not only within the foot but also to knees, hips and the back. This presentation discusses a new proven procedure that may be able to help realign and there fix this problem at its root.

    Friday, October 5, 2012

    GIII® Announces Recipient of the 2012 “Game Changer” Award

    Leading Chinese Foot and Ankle Surgeon Bestowed Title of GIII® 2012 “Game Changer”.

    The 2012 “Game Changer” award, presented by the Graham International Implant Institute®, the training partner of GraMedica®, a global orthopedic medical device company, was presented to one of the leading foot and ankle specialists in all of China. Dr. Jian Zhong Zhang, M.D., Prof., Director of Foot and Ankle Services, Chief of the Department of Orthopaedics at Beijing TongRen Hospital and Capital Medical University, received the award during a ceremony at the 2012 TongRen Foot and Ankle Symposium, held in Beijing, China, September 14-16.

    Read more. 

    Thursday, October 4, 2012

    Changing Lives, One Step at a Time: HyProCure® Marks 8 Years


    HyProCure® was invented by Michael E. Graham, DPM, FACFAS, FAENS. In his practice, Dr. Graham specialized in the correction of foot and ankle instability. Recognizing the significant limitations of the sinus tarsi implants on the market, he developed HyProCure®. The device received FDA approval on September 16, 2004 and the first HyProCure® placement took place on September 22, 2004. As more and more doctors and patients gained awareness of both the condition and treatment, GraMedica®, global orthopedic medical device company and maker of HyProCure®, experienced rapid growth.

    Dr. Graham was determined to improve patient outcomes by providing this revolutionary solution. In order to share his knowledge and expertise with other foot and ankle surgeons, he founded the Graham International Implant Institute® (GIII®) in August 2006. The mission of GIII® is to elevate the standard of care in the arena of Extra-Osseous TaloTarsal Stabilization through education. Since the release of HyProCure®, many peer-reviewed studies have been published recognizing the proven results of this EOTTS device. Learn more at http://www.gramedica.com/library/.

    Wednesday, October 3, 2012

    Why is HyProCure® Different from Other Devices?

    A New Kind of TaloTarsal Stabilization

    One of the most important advantages of the HyProCure® system is the procedure itself. The actual surgery is minimally invasive, generally takes less than 15 minutes, requires only local anesthetic, and can actually be performed in-office, which makes it ideal for patients without insurance coverage.

    While the procedure is similar in principle to subtalar devices, there are several very important differences that need to be reviewed before you can perform the HyProCure® procedure safely and effectively. To aid you with this, we have prepared a fast-track online training program that will arm you with the core preparation to successfully perform the procedure. In addition, we also offer many hands-on training seminars year-round and throughout the world that can assist you in advancing your training and certification status.

    The complete details of the HyProCure® procedure itself will be covered during your training and certification process, whether online or at one of our seminars. We also invite you to review the procedure animation video below for a guided overview of the process.

    If you are a specialist interested in HyProCure training, please click here.

    Monday, October 1, 2012

    HyProCure® in Pediatric Patients

    Q. What happens to a pediatric patient when they mature and their bones grow to their adult size, will we need to revise the HyProCure® stent size?

    A. By the time a child is 3 to 4 years old the sinus tarsi is formed by the osseous structures from the talus and calcaneus. It is my belief that the sinus tarsi does not change in its dimensions (yet to be proven). This is based on the fact the most common HyProCure® size is 7 then 6 in adult patients. So, if a child already has a size 6 or 7, then they already have the most common adult size stent. 



    Learn more at www.GraMedica.com.

    Sunday, September 30, 2012

    HyProCure® Surgeon Training


    Get qualified in GraMedica® Products and Surgical Techniques or find a Lecture & Hands-on Workshop.

    Through our training partner, the Graham International Implant Institute (GIII), we are committed to research, training, certification and support on implantology for foot physicians worldwide.

    Learn more at www.GraMedica.com.

    Thursday, September 27, 2012

    HyProCure®: A Life Changing Solution

    HyProCure® has been created to provide the best solution to a recurrent/flexible displacement of the talotarsal mechanism. This extra-osseous talotarsal stabilization device transposes the negative space of the sinus tarsi into a positive space. Due to the unique design of HyProCure®, utilizing both the canalis and sinus portion of the sinus tarsi, it restores normal triplane motion while eliminating the excessive motion of the talus on the calcaneus and helping to prevent weightbearing navicular drop. Learn more here.

    Thursday, September 20, 2012

    HyProCure® Classified as a Type II Device: Improved Design and Function

    The Journal of Foot & Ankle Surgery Article, September 2012

    Extra-Osseous Stabilization Devices: A New Classification System. Visit http://www.jfas.org/article/S1067-2516(12)00242-6/abstract for the article abstract.

    Clinical Significance & Conclusions
    • The partial/recurrent dislocation of the talus on the tarsal mechanism is a triplane deformity. Displacement on any one of the four articular facets of the TTM leads to displacement at the other facets.
    • The ideal method to stabilize the TTM is exactly at the axis of triplanar talotarsal motion. In the TTM, this is referred to as the “cruciate pivot point” and is generally located at the entrance of the canalis tarsi along the longitudinal talar bisection line.
    • It has been acknowledged that a device that better matches the anatomical shape of the tarsal sinus and follows its natural orientation would allow for better biomechanical functioning.
    • Only Type II devices meet the ideal parameters, which has an impact on their improved success rates.
    • This improved design and function may also contribute to the success of Type II devices in decreasing the effects of or even eliminating secondary pathologies.

    Monday, September 17, 2012

    New Published Research on HyProCure®: Radiographic Outcomes in Adult Patients

    The Journal of Foot & Ankle Surgery Article, September 2012Surgical Treatment of Hyperpronation Using an Extra-Osseous TaloTarsal Stabilization Device: Radiographic Outcomes in Adult Patients. Visit http://www.jfas.org/article/S1067-2516(12)00239-6/abstract for the article abstract.

    Clinical Significance & Conclusions
    • The results of the postoperative radiographic correction prove that transverse and sagittal plane normalization occurs. Since talotarsal motion is triplanar, correction of two of the three cardinal planes will result in triplane correction.
    • EOTTS with HyProCure® was effective in controlling motion in the desired planes without causing overcorrection or blocking in other planes.
    • Stabilization of the TTM with HyProCure® is effective in restoring the normal range of pronation and supination, which is essential for the reduction of strain and force on the soft tissues and osseous structures of the foot and ankle.


    Saturday, September 15, 2012

    HyProCure®: A Real Solution for Flexible TaloTarsal Displacement

    Talotarsal dislocation (partial) is a condition affecting people of all ages throughout the world. It occurs when the ankle bone displaces off of its normal position and its contact points on the hind-foot bones—in other words, when the balance and alignment of the ankle bone on the heel bone is lost. This displacement creates an abnormal, inward rotation of the ankle bone and outer rotation of the rest of the foot, which in turn creates a fundamental imbalance of forces and weight distribution both in the foot itself, as well as in the rest of the body.

    When partial talotarsal dislocation occurs, it creates a damaging misalignment of forces both in the foot itself, as well as throughout the entire body. This is because the rear-foot is the center point of our body’s balance and weight distribution during walking and standing. As a consequence, talotarsal displacement can be the direct cause of numerous foot ailments, including low arches, plantar fasciitis or heel pain, overpronation, bunions, heel spurs, and more – as well as the direct cause of symptoms in the rest of the body such as knee pain, hip pain, back pain and even complications in the neck and shoulders.

    HyProCure® represents a real solution for flexible talotarsal displacement and its devastating effects throughout the body. It instantly corrects the problem at its root and immediately works on improving and even reversing many of the symptoms and secondary conditions resulting from this deformity. These include low arches, overpronation, plantar fasciitis or heel pain, knee pain, hip pain, back pain, and many others, both in children and adults.

    Instantly following the HyProCure® procedure, the ankle bone is stabilized. The arch may be more prominent and the overall balance and alignment will be improved.

    The bones, tendons and ligaments throughout the foot and the rest of the body will continue to adapt to the new position over the following several months.

    Learn more at www.GraMedica.com.

    Saturday, September 8, 2012

    Indications for the HyProCure® Procedure


    HyProCure® is a talotarsal stabilization device used in the treatment of talotarsal displacement and resulting sequela. The implant is designed to stabilize the talus on the tarsal mechanism to prevent excessive anterior, and/or medial and/or plantarflexion of the talus on the tarsal mechanism, while allowing normal talotarsal joint motion.






    The ideal candidate:

    • Exhibits partial talotarsal dislocation as evidenced by pathologic hindfoot motion and confirmed by radiographic analysis.
    • Is older than three years of age.
    • Has good protoplasm.
    • Has a reducible/flexible deformity.

    Learn the contra-indications and how to verify candidacy at www.GraMedica.com.

    Thursday, September 6, 2012

    What is Talotarsal Joint Dislocation?


    Talotarsal displacement is a pathologic condition that will not "fix" itself. This condition leads to excessive strain on the structures within the foot and ankle as well as to the knees, hips and back while standing, walking, or running. There are clear clinical and radiographic signs that are used to diagnose this disease as well as to show improvement after treatment. Unfortunately, this disease is usually ignored or over-looked while the focus of attention is aimed at the secondary symptoms rather than to the realignment of what lead to the development of those secondary symptoms.

    Sunday, September 2, 2012

    Flatfoot versus Talotarsal Displacement

    Flat feet are a common problem that traditionally have been ignored or treated with extensive surgery. It is possible that there is a dislocation of the ankle bone (talus) on the hindfoot bones leading to a mis-alignment. A new evidence-based procedure is available that is a real "game" changer. View this presentation to learn more.

    Friday, August 31, 2012

    Orthotics Biomechanics

    Biomechanics of the foot simplified and a close look at the function of foot arch supports.

    Thursday, August 16, 2012

    GraMedica® Exhibiting at the The National - APMA Annual Scientific Meeting

    The National -  - American Podiatric Medical Association's Annual Scientific Meeting in Washington, DC started strong this morning with a standing ovation after the opening speech given by United States Surgeon General, Regina Benjamin, MD, MBA.

    Following was the Grand Opening of the exhibit hall. This years exhibit hall features more than 200 exhibitors, close to 300 booths, and all the latest podiatric products. As a proud sponsor of the APMA, GraMedica® is very excited to be here celebrate 100 years advancing podiatric medicine.

    Stop by our booth, #715, and learn about GraMedica®'s innovative products. A complete Exhibitor Directory is available.

    Couldn't make it to The National? Learn about our innovative products, including HyProCure®, osteo-WEDGETM and Soleus® at www.GraMedica.com.

    Friday, August 10, 2012

    Why Choose HyProCure®?



    This pioneering device is placed deep into the canalis portion of the sinus tarsi, reestablishing the normal pivot over which the talus (ankle bone) glides, thereby properly realigning the foot and ankle bones and restoring normal function. HyProCure® received FDA approval on September 16, 2004. The first HyProCure® placement took place on September 22, 2004.

    Learn more here>>>

    Thursday, August 9, 2012

    APMA National Meeting 2012


    GraMedica® is a proud sponsor of the America Podiatric Medical Association.

    We are excited to announce that we will be exhibiting at The National 2012 APMA Annual Scientific Meeting August 16-19, in Washington, DC. The National is the podiatric medical profession's premier foot and ankle conference.

    Stop by and visit with the GraMedica® team at booth #715 and 717.

    Dr. Michael E. Graham, President and Founder of GraMedica® will be giving a lecture: "Talotarsal Joint Mechanics - It All Starts Here" on Friday, August 17, from 11:30am-12:00pm. We hope to see you there.

    Learn more about the APMA National and get the full agenda here.

    This year marks the 100th Anniversary of the APMA and we look forward to celebrating their continued success and advancements in podiatric medicine during the National Meeting.

    Learn more about GraMedica®, a global orthopedic medical device company and leader in foot care solutions at www.GraMedica.com. Our products are developed to correct the root problem, not merely treat the symptoms. All products are developed by surgeons with years of experience in their own practices.



    Monday, August 6, 2012

    Advantages of the osteo-WEDGETM Bone Locking Plate and Screw System

    What are the advantages of the osteo-WEDGETM Bone Locking Plate and Screw System?

    The osteo-WEDGETM system was designed to overcome the limitations of other devices and procedures.

    Advantages include:
    • Ability to lengthen, shorten or maintain metatarsal length
    • Ability to plantarflex or dorsiflex the metatarsal – sagittal plane correction
    • Ability to correct an increased first metatarsal angle – transverse plane correction
    • Dorsomedial application at the 1st metatarsal medial cuneiform joint to counteract weight bearing forces
    • Six points (three proximally and three distally) of locking screw fixation for maximum stability
    • Thin (1mm), low profile, but strong titanium configuration
    • Allows for easy and accurate placement
    • May allow for early weightbearing

    Sunday, August 5, 2012

    Meidcal Device Company Promotes the Importance of Caring for Children’s Feet

    GraMedica® is a global orthopedic medical device company and leader in foot care solutions. Recognized for its innovation, the company is producer of breakthrough products like HyProCure® and osteo-WEDGETM.

    GraMedica® is proud to be a corporate sponsor of the American College of Foot and Ankle Pediatrics and to support their mission of education on the importance of caring for children’s feet.

    Read full article...

    Saturday, August 4, 2012

    Doctor Entrusts Own Family’s Health to HyProCure®


    Surgeon believes in product and ease of performing Extra-Osseous TaloTarsal Stabilization (EOTTS) with HyProCure® enough to let his family member undergo the surgery.

    International HyProCure® Surgeon and HyProCure® Instructor, Elie Daniel, DPM (Mendota, IL) seeks opportunities to share his personal experience with the device. Having multiple practices in the United States and a practice in Lebanon, he helps patients all over the world. Not only does Dr. Daniel travel internationally to perform EOTTS with HyProCure®, he is also always willing to train other surgeons interested in performing the procedure.

    Read full article here...

    Friday, August 3, 2012

    Innovative Medical Device Now Available to Patients in China

    HyProCure® Extra-Osseous TaloTarsal Stabilization (EOTTS) device offered as a superior treatment option to patients in China following the first HyProCure® procedures performed in the country.
    Read full article...

    Tuesday, July 31, 2012

    The HyProCure® Advantage

    HyProCure® offers a superior option in the treatment of flexible talotarsal joint dislocation, for patients ages three and up. Unlike any other talotarsal mechanism stabilization device, HyProCure® has inherent advantages that make this minimally invasive procedure the ideal solution for the vast majority patients from all walks of life.

    This stent’s advanced design utilizes both the sinus and canalis portions of the sinus tarsi, yielding the best anatomical fit and biomechanical correction. These factors contribute to the low removal rate and high patient satisfaction, which in turns translates into great professional success for the physician.

    Most importantly, HyProCure® has more peer-reviewed published literature to support its claims than any other device on the market. Links to abstracts of the published literature can be found in our Library section.

    Click here to review points that will help explain the dramatic breakthrough that HyProCure® represents -->

    Implementing HyProCure®

    Getting Started with HyProCure®:

    The first step in implementing HyProCure® into your practice is to train. This can be done through our interactive online training available at www.GraMedica.com. We also offer Lecture and Hands-on Cadaver Workshops worldwide, where you can become qualified with GraMedica® products including HyProCure®.

    After completion of either training option, you will then be introduced to our downloads and resources, where we have many tools available to help you implement HyProCure® into your practice.

    Upon completion of training, a HyProCure® representative will also contact you to assist with ordering the HyProCure® system.
    The HyProCure® system consists of a set of trial sizers, the impant driver, guide wire (optional) and stents. The complete set is shipped out for each procedure and returned to us after the fact, minus the stent size used on the patient.

    The kit is available for order through the facility where the procedure will be performed, or directly to the doctor’s office for in-office cases.

    Learn more at www.GraMedica.com.

    Friday, July 27, 2012

    GraMedica® Celebrates 9 Years

    Global orthopedic medical device company marks their 9th year providing superior treatment options.

    GraMedica® is a global orthopedic medical device company and leader in the development of life-changing foot and ankle products. Founded in 2003, GraMedica® has experienced dynamic growth, reaching more than 25 countries. All of GraMedica®’s products are developed to correct the root problem, not merely treat symptoms. Recognized for its innovation, the company is the producer of breakthrough products like HyProCure® and osteo-WEDGETM.

    HyProCure® has Scientifically Proven Results

    In a recent study, HyProCure® was scientifically proven to have a less than 6% removal rate and is highly effective in the treatment of partial talotarsal dislocation.

    The study was published by The Journal of Foot and Ankle Science.
    Extraosseous Talotarsal Stabilization Using HyProCure® in Adults: A 5-year Retrospective Follow-up. Visit http://www.jfas.org/article/S1067-2516(11)00576-X/abstract for the article abstract.

    Read the summary here.

    Thursday, July 26, 2012

    Heel Pain/Plantar Fasciitis Solution

    There are many treatments commonly used to address plantar fasciitis, ranging from icing the area to prescription drugs and all the way to surgery, involving the partial to full release of the plantar fascia. These therapies are sometimes helpful to address the inflammation and degeneration that occurs to the plantar fascia, but all they can offer is a relief of the symptoms, which is usually temporary. The true cause of the damage in the first place is the excessive inward rotation of the foot as a direct result of talotarsal displacement. As such, until this root cause is corrected, the symptoms on the plantar fascia are bound to return and worsen.

    We invite you to learn more about talotarsal displacement and about HyProCure®, a permanent, minimally invasive solution that corrects the problem at its root.



    HyProCure® Online Training



    In order to arm physicians with the core knowledge to successfully perform the HyProCure® procedure, we have created an interactive online training designed to fast-track practicing surgeons.

    In order to get started with the training program, please complete the doctor registration form. A personalized link to your training session will be sent to the email address provided shortly thereafter. With this link you will be able to get started with your training right away, as well as resume your session at your convenience should you need to interrupt it. Detailed instructions will be provided in both the training invitation email as well as the training module itself.

    Proceed to the Online Training >

    Wednesday, July 25, 2012

    HyProCure® Physician Testimonials

    Find out what physicians think about the HyProCure® Solution and how they have implemented it into their practice.

    Testimonials from HyProCure® Surgeons




    Benefits & Alternatives to HyProCure®

    The HyProCure® solution is the best of its kind. It’s minimally-invasive, very fast and relatively atraumatic. HyProCure® offers a permanent, yet reversible, option for the condition of partial/flexible talotarsal dislocation. HyProCure® provides internal correction for an internal deformity.
    Learn more on why HyProCure® is better.

    Aside from laterally-anchored-designed devices, which have a relatively high removal rate, several other alternatives are still being used to treat the condition. Some common options include orthotics, leg braces, orthopedic shoes, physical therapy, and even reconstructive rear foot surgery, among other things. These alternate methods ultimately fail to give the patient a reliable, life-long answer, and often cause more problems than solutions. All this in turn ends up in unsatisfied patients and frustrated doctors.
    Learn more about the alternatives.

    Tuesday, July 24, 2012

    HyProCure® Training Workshop


    Through our training partner, the Graham International Implant Institute (GIII), we are committed to research, training, certification and support on implantology for foot physicians worldwide.

    Our next Lecture and Hands-on Cadaver Workshop is set to take place in Phoenix, AZ:

    AUG 25, 2012
    Pointe Hilton Squaw Peak Resort, 7677 North 16th St.
    Phoenix, AZ 85020


    The seminar is a full-day training program of lecture and a hands-on cadaver workshop. The seminar will take place from 8:00am - 2:00pm and will include a light breakfast and boxed lunch. The seminar will cover Extra-Osseous TaloTarsal Stabilization with HyProCure® as well as treatment of first ray deformities with the osteo-WEDGETM Opening Wedge Bone Locking Plate System.

    Apply online

    Can't make it to the workshop? Train online today!

    Indications and Contra-Indications for HyProCure®

    HyProCure® is a talotarsal stabilization device used in the treatment of talotarsal displacement and resulting sequela. The implant is designed to stabilize the talus on the tarsal mechanism to prevent excessive anterior, and/or medial and/or plantarflexion of the talus on the tarsal mechanism, while allowing normal talotarsal joint motion.

    Learn about the Indications and Contra-Indications for HyProCure® at www.GraMedica.com.



    Monday, July 23, 2012

    osteo-WEDGETM Bunion Correction

    Traditional bunion corrective surgical techniques are like cutting a wedge out of the leaning tower of Pisa to make it straight when the real problem was with the foundation. The osteo-WEDGETM Open Wedge Bone Locking System fixes the deformity at its foundation. With osteo-WEDGETM, patients and foot surgeons have a new option for permanent correction, without the limitations of other methods. The procedure is less invasive and patient should experience a quicker recovery than they would with the alternates.

    TaloTarsal Displacement: Clinical Signs

    Talotarsal dislocation (partial) is a condition affecting people of all ages throughout the world. It occurs when the ankle bone displaces off of its normal position and its contact points on the hind-foot bones—in other words, when the balance and alignment of the ankle bone on the heel bone is lost. This displacement creates an abnormal, inward rotation of the ankle bone and outer rotation of the rest of the foot, which in turn creates a fundamental imbalance of forces and weight distribution both in the foot itself, as well as in the rest of the body.

    When partial talotarsal dislocation occurs, it creates a damaging misalignment of forces both in the foot itself, as well as throughout the entire body. This is because the rear-foot is the center point of our body’s balance and weight distribution during walking and standing. As a consequence, talotarsal displacement can be the direct cause of numerous foot ailments, including low arches, plantar fasciitis or heel pain, overpronation, bunions, heel spurs, and more – as well as the direct cause of symptoms in the rest of the body such as knee pain, hip pain, back pain, and even complications in the neck and shoulders.


    Clinical Signs of Partial TaloTarsal Dislocation.


    Friday, July 20, 2012

    HyProCure® Expands Global Reach: Now Available to Patients in Italy

    Extra-Osseous TaloTarsal Stabilization (EOTTS) Device gaining recognition across the globe with the latest addition of distribution in Italy.

    Three EOTTS with HyProCure® procedures were recently performed in Italy, intiating the device into the country. Three surgeons, Prof. La Rosa of “Bambino Gesu,” the Vatican’s Pediatric Hospital in Rome, Prof. Giglio and MD Offiano each offered this revolutionary treatment option to their patients.

    Read More:
    HyProCure® Expands Global Reach: Now Available to Patients in Italy





    Thursday, July 19, 2012

    GraMedica® Supports Medical Care for Crippled Children from the Yucatan Peninsula | PRLog

    GraMedica® Supports Medical Care for Crippled Children from the Yucatan Peninsula | PRLog

    Active Mother of Two Shows off Her “New Arches” after Life-changing HyProCure® Procedure | PRLog

    Active Mother of Two Shows off Her “New Arches” after Life-changing HyProCure® Procedure | PRLog

    Chinese Surgeon Travels Internationally to Collaborate with a “Master” HyProCure® Surgeon | PRLog

    Chinese Surgeon Travels Internationally to Collaborate with a “Master” HyProCure® Surgeon | PRLog

    HyProCure® and osteo-WEDGETM Training Available

    Become qualified with GraMedica® Products and Surgical Techniques or find a Lecture & Hands-on Workshop.

    Through our training partner, the Graham International Implant Institute(GIII), we are committed to research, training, certification and support on implantology for foot physicians worldwide.

    We offer interactive online training as well as lecture and hands-on cadaver courses for both HyProCure® and osteo-WEDGETM.

    Register Now:
    HyProCure® Online Training
    osteo-WEDGETM Online Training
    Lecture and Hands-on Cadaver Workshops


    Friday, July 13, 2012

    Learn About GraMedica®

    Welcome to the GraMedica® blog. Here we will share the most up-to-date information on our company products and resources. To get know us better, take a moment to learn more about our Company History, the GraMedica® Mission, our Core Beliefs and our Founder.